Phase I study on the sequential administration of recombinant human interferon-γ and recombinant human interleukin-2 in patients with metastatic solid tumors

Johanna W. Baars, John Wagstaff, Epie Boven, Jan B. Vermorken, Cees J. Van Groeningen, Riekeld J. Scheper, Johanna C M Fonk, Hans W. Nijman, Christopher R. Franks, Otto Damsma, Herbert M. Pinedo

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1408-1410
Number of pages3
JournalJournal of the National Cancer Institute
Volume83
Issue number19
StatePublished - Oct 2 1991
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging

Cite this

Baars, J. W., Wagstaff, J., Boven, E., Vermorken, J. B., Van Groeningen, C. J., Scheper, R. J., Fonk, J. C. M., Nijman, H. W., Franks, C. R., Damsma, O., & Pinedo, H. M. (1991). Phase I study on the sequential administration of recombinant human interferon-γ and recombinant human interleukin-2 in patients with metastatic solid tumors. Journal of the National Cancer Institute, 83(19), 1408-1410.